Regeneron Pharmaceuticals, Inc
REGN NASDAQ

REGN
Regeneron Pharmaceuticals, Inc NASDAQ
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

REGN financial statements

The current financial position of Regeneron Pharmaceuticals, Inc

Total assets of REGN for Q2 21 is 21.49B, 20.90% more than the previous Q1 21. And total liabilities increased by 9.72% in Q2 21 to 6.36B.

Total assets
Total current assets
Total non-current assets
Total liabilities
Total current liabilities
Total non-current liabilities
Total equity
Total liabilities & shareholders' equities
Total debt
Book value per share